Does TARLATAMAB-DLLE Cause Incorrect dose administered? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Incorrect dose administered have been filed in association with TARLATAMAB-DLLE (IMDELLTRA (AMG757)). This represents 0.8% of all adverse event reports for TARLATAMAB-DLLE.
6
Reports of Incorrect dose administered with TARLATAMAB-DLLE
0.8%
of all TARLATAMAB-DLLE reports
1
Deaths
2
Hospitalizations
How Dangerous Is Incorrect dose administered From TARLATAMAB-DLLE?
Of the 6 reports, 1 (16.7%) resulted in death, 2 (33.3%) required hospitalization.
Is Incorrect dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TARLATAMAB-DLLE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TARLATAMAB-DLLE Cause?
Cytokine release syndrome (274)
Immune effector cell-associated neurotoxicity syndrome (127)
Off label use (111)
Pyrexia (75)
Small cell lung cancer (66)
Death (45)
Disease progression (34)
Metastases to central nervous system (28)
Decreased appetite (23)
Dysgeusia (22)
What Other Drugs Cause Incorrect dose administered?
TIRZEPATIDE (23,301)
ADALIMUMAB (14,000)
DUPILUMAB (9,907)
RANITIDINE (9,337)
INSULIN LISPRO (8,318)
ACETAMINOPHEN (5,316)
DULAGLUTIDE (5,207)
SECUKINUMAB (4,524)
INSULIN GLARGINE (3,070)
SOMATROPIN (2,772)
Which TARLATAMAB-DLLE Alternatives Have Lower Incorrect dose administered Risk?
TARLATAMAB-DLLE vs TASIGNA
TARLATAMAB-DLLE vs TASIMELTEON
TARLATAMAB-DLLE vs TAVABOROLE
TARLATAMAB-DLLE vs TAXOL
TARLATAMAB-DLLE vs TAXOTERE